Safety of Stopping Treatment for Mycobacterium avium Complex Infection in Patients with AIDS
Journal: Annals of Internal Medicine (2002)

Summaries for Patients5 November 2002Safety of Stopping Treatment for Mycobacterium avium Complex Infection in Patients with AIDSSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-9-200211050-00004 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?HIV-infected patients are susceptible to other infections because the virus itself damages the body's ability to ward off invasion by other germs, even those that are too weak to infect healthy people. These secondary infections by weak germs are known as opportunistic infections. One of the most common opportunistic infections is caused by an organism known as Mycobacterium avium complex (MAC). Effective therapy for HIV infection (which consists of combinations of medications known as highly active antiretroviral therapy [HAART]) partially restores the body's ability to ward off opportunistic ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Successful Discontinuation of Therapy for Disseminated Mycobacterium avium Complex Infection after Effective Antiretroviral Therapy.” It is in the 5 November 2002 issue of Annals of Internal Medicine (volume 137, pages 734-737). The authors are SD Shafran, LD Mashinter, P Phillips, RG Lalonde, MJ Gill, SL Walmsley, E Toma, B Conway, IW Fong, AR Rachlis, KE Williams, GE Garber, WF Schlech III, and F Smaill.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. Previousarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoSuccessful Discontinuation of Therapy for Disseminated Mycobacterium avium Complex Infection after Effective Antiretroviral Therapy Stephen D. Shafran , Laura D. Mashinter , Peter Phillips , Richard G. Lalonde , M. John Gill , Sharon L. Walmsley , Emil Toma , Brian Conway , Ignatius W. Fong , Anita R. Rachlis , Kurt E. Williams , Gary E. Garber , Walter F. Schlech III , and Fiona Smaill Metrics 5 November 2002Volume 137, Issue 9Page: I-48KeywordsAntiretroviral therapyChartsHIV infectionsHighly active antiretroviral therapyInfectious diseasesMedical servicesMycobacterium avium complexOpportunistic infectionsPreventive medicineSafety ePublished: 5 November 2002 Issue Published: 5 November 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...